UP202-56
Product Specifications
UNSPSC Description
UP202-56 is an adenosine analogue, which is an adenosinergic agonist.
Target Antigen
Adenosine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/UP202-56.html
Solubility
10 mM in DMSO
Smiles
O[C@H]1[C@@H](O[C@@H]([C@H]1O)C(NC2CC2)=O)N3C4=NC=NC(NCCC(C5=C6)=CN(CC7=C(C=CC(C)=C7)C)C5=CC=C6C)=C4N=C3
Molecular Weight
595.69
References & Citations
[1]Honoré P, et al. UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression. Pain. 1998 Apr;75(2-3):281-93.|[2]Camborde, Francois, et al. PHARMACEUTICAL COMBINATION WITH ANALGESIC ACTIVITY, CONTAINING AN ADENOSINERGIC AGONIST AND A COMPOUND SELECTED FROM OPIATES, BENZODIAZEPINES AND NMDA ANTAGONISTS. Patent Application WO/1999/029347.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-U00226/UP202-56-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-U00226/
Clinical Information
No Development Reported
CAS Number
163838-04-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1469512-01 0.02 mg (E-Coli)
Recombinant Macropus eugenii Beta-lactoglobulin (LGB)
Ask
View Details